Stryker Corporation Stock

Equities

SYK

US8636671013

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:03 2024-05-31 pm EDT 5-day change 1st Jan Change
340.6 USD +0.01% Intraday chart for Stryker Corporation +1.50% +13.73%
Sales 2024 * 22.3B Sales 2025 * 24B Capitalization 130B
Net income 2024 * 3.91B Net income 2025 * 4.48B EV / Sales 2024 * 6.15 x
Net Debt 2024 * 7.26B Net Debt 2025 * 4.47B EV / Sales 2025 * 5.6 x
P/E ratio 2024 *
33.3 x
P/E ratio 2025 *
29.1 x
Employees 52,000
Yield 2024 *
0.97%
Yield 2025 *
1.06%
Free-Float 94.61%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.01%
1 week+1.50%
Current month-0.15%
1 month+1.21%
3 months-2.44%
6 months+14.93%
Current year+13.73%
More quotes
1 week
335.77
Extreme 335.77
344.86
1 month
322.50
Extreme 322.5
344.86
Current year
292.43
Extreme 292.43
361.41
1 year
249.98
Extreme 249.98
361.41
3 years
188.84
Extreme 188.84
361.41
5 years
124.54
Extreme 124.54
361.41
10 years
77.87
Extreme 77.87
361.41
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 11-04-24
Director of Finance/CFO 62 02-12-31
Chief Tech/Sci/R&D Officer - 14-12-31
Members of the board TitleAgeSince
Director/Board Member 80 73-12-31
Director/Board Member 65 18-05-01
Director/Board Member 89 77-01-31
More insiders
Date Price Change Volume
24-05-31 341.1 +0.17% 2,175,319
24-05-30 340.5 -0.18% 1,347,259
24-05-29 341.1 +0.54% 1,918,939
24-05-28 339.3 +1.12% 1,872,435
24-05-24 335.5 +1.64% 1,230,572

Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT

More quotes
Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
341.1 USD
Average target price
373.1 USD
Spread / Average Target
+9.38%
Consensus